SCHEMBL4113322

SCHEMBL4113322

O=C(NCc1ccccc1)Nn1ccc2cc(Cl)ccc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
MDM2 Q00987 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
OXER1 Q8TDS5 1/20 0.41
FBP1 P09467 1/20 0.41
KCNA5 P22460 1/20 0.41
CNR1 P21554 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508129 0.84 KDM4E (0.48) KMT2AALDH1A1MAPTLMNAHPGD
SCHEMBL4101401 0.82 OXER1 (0.46) RXFP1OXER1
SCHEMBL4103818 0.81 KMT2A (0.50) MEN1KMT2AALDH1A1MAPTRXFP1
SCHEMBL4103018 0.74 HTT (0.51) ALDH1A1MAPTGAA
SCHEMBL28980321 0.74 OXER1 (0.43) KMT2AALDH1A1RXFP1HPGDKDM4E
SCHEMBL27777662 0.74 OXER1 (0.43) ALDH1A1RXFP1KDM4EGAAOXER1
SCHEMBL8836401 0.73 OXER1 (0.44) RXFP1OXER1
SCHEMBL4101233 0.73 RAB9A (0.52) MEN1KMT2ALMNAHPGDTP53
SCHEMBL4113201 0.71 KMT2A (0.52) MEN1KMT2AMAPTMDM2LMNA
SCHEMBL3840124 0.71 KDM4E (0.52) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009106753-A1 NOVEL DERIVATIVES OF 1H-INDOL-1-YL UREA, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2009-09-03 WO disclosed
EP-2078716-A1 New derivatives of 1H-indol-1-yl-urea, method for preparing same and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2009-07-15 EP disclosed
US-20090176794-A1 1H-INDOL-1-YL-UREA COMPOUNDS LES LABORATOIRES SERVIER (FR) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176794-A1 1H-INDOL-1-YL-UREA COMPOUNDS TPH1, HTR1D, IDO1 BACE1 149/4885MEN1 2140/4885KMT2A 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.